Cisen Pharmaceutical Co Ltd (603367) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.050x

Based on the latest financial reports, Cisen Pharmaceutical Co Ltd (603367) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥311.93 Million ≈ $45.64 Million USD) by net assets (CN¥6.19 Billion ≈ $906.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cisen Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Cisen Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 603367 current and long-term liabilities for a breakdown of total debt and financial obligations.

Cisen Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cisen Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Altareit PA:AREIT	0.051x
Jiangsu LiXing General Steel Ball Co Ltd SHE:300421	0.009x
Chengdu Guibao Science Tech SHE:300019	0.079x
Episil-Precision Inc TW:3016	0.019x
JC Finance & Tax Interconnect Holdings Ltd SHE:002530	0.018x
ARB Corporation Ltd AU:ARB	0.087x
Helix Energy Solutions Group Inc NYSE:HLX	0.015x
CTCI Corp TW:9933	0.417x

Annual Cash Flow Conversion Efficiency for Cisen Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Cisen Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Cisen Pharmaceutical Co Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥5.99 Billion ≈ $876.08 Million	CN¥570.85 Million ≈ $83.53 Million	0.095x	+21.85%
2023-12-31	CN¥5.77 Billion ≈ $843.81 Million	CN¥451.24 Million ≈ $66.03 Million	0.078x	+62.23%
2022-12-31	CN¥5.36 Billion ≈ $783.73 Million	CN¥258.35 Million ≈ $37.80 Million	0.048x	+4.39%
2021-12-31	CN¥5.06 Billion ≈ $739.79 Million	CN¥233.60 Million ≈ $34.18 Million	0.046x	-48.52%
2020-12-31	CN¥4.80 Billion ≈ $702.68 Million	CN¥431.01 Million ≈ $63.07 Million	0.090x	+126.48%
2019-12-31	CN¥4.57 Billion ≈ $669.29 Million	CN¥181.26 Million ≈ $26.52 Million	0.040x	-59.51%
2018-12-31	CN¥4.15 Billion ≈ $608.01 Million	CN¥406.68 Million ≈ $59.51 Million	0.098x	-17.08%
2017-12-31	CN¥3.72 Billion ≈ $544.98 Million	CN¥439.61 Million ≈ $64.33 Million	0.118x	-7.08%
2016-12-31	CN¥2.30 Billion ≈ $336.34 Million	CN¥291.97 Million ≈ $42.72 Million	0.127x	+0.13%
2015-12-31	CN¥2.10 Billion ≈ $307.11 Million	CN¥266.24 Million ≈ $38.96 Million	0.127x	+775.81%
2014-12-31	CN¥1.90 Billion ≈ $278.19 Million	CN¥27.54 Million ≈ $4.03 Million	0.014x	-69.23%
2013-12-31	CN¥1.73 Billion ≈ $252.63 Million	CN¥81.26 Million ≈ $11.89 Million	0.047x	+125.43%
2012-12-31	CN¥1.58 Billion ≈ $231.88 Million	CN¥33.09 Million ≈ $4.84 Million	0.021x	-63.20%
2011-12-31	CN¥1.34 Billion ≈ $196.74 Million	CN¥76.28 Million ≈ $11.16 Million	0.057x	--

About Cisen Pharmaceutical Co Ltd

SHG:603367 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.04 Billion

CN¥7.11 Billion CNY

Market Cap Rank

#8964 Global

#2395 in China

Share Price

CN¥15.70

Change (1 day)

+0.96%

52-Week Range

CN¥13.42 - CN¥34.05

All Time High

CN¥34.05